Literature DB >> 26647227

Endovascular revascularization of symptomatic chronic middle cerebral artery occlusions: Two case reports.

Yue Wan1, Wai-Ting Lo2, Yang-Xia Liu1, Xiao-Xiang Peng3.   

Abstract

For patients with chronic middle cerebral artery occlusions who have recurrent ischemic symptoms despite antiplatelet therapy and vascular risk factor control, treatment options are limited. Because of concerns about the safety of endovascular revascularization of these occlusions and the technical skills required, these procedures have not been widely performed. We report on two patients with successful endovascular revascularization of the chronic middle cerebral artery occlusion with impaired cerebral hemodynamics, with vessel patency maintained on follow-up imaging and no recurrence of stroke. A literature review of treatment options for such patients was performed. Revascularization is technically feasible and can be considered an option for carefully selected chronic middle cerebral artery occlusion patients with recurrent ischemic symptoms despite medical therapy.
© The Author(s) 2015.

Entities:  

Keywords:  Angioplasty; endovascular therapy; middle cerebral artery; occlusion

Mesh:

Year:  2015        PMID: 26647227      PMCID: PMC4757387          DOI: 10.1177/1591019915617316

Source DB:  PubMed          Journal:  Interv Neuroradiol        ISSN: 1591-0199            Impact factor:   1.610


  9 in total

Review 1.  Global burden of intracranial atherosclerosis.

Authors:  Lawrence K S Wong
Journal:  Int J Stroke       Date:  2006-08       Impact factor: 5.266

2.  Solitaire stents for the treatment of complex symptomatic intracranial stenosis after antithrombotic failure: safety and efficacy evaluation.

Authors:  Guoli Duan; Zhengzhe Feng; Lei Zhang; Ping Zhang; Lei Chen; Bo Hong; Yi Xu; Wenyuan Zhao; Jianmin Liu; Qinghai Huang
Journal:  J Neurointerv Surg       Date:  2015-06-03       Impact factor: 5.836

3.  Extracranial-intracranial (EC-IC) bypass of symptomatic middle cerebral artery (MCA) total occlusion for haemodynamic impairment patients.

Authors:  Chii-Wen Chou; Ju-Hsin Chang; Shinn-Zong Lin; Der-Yang Cho; Ya-Wen Cheng; Chun-Chung Chen
Journal:  Br J Neurosurg       Date:  2012-05-18       Impact factor: 1.596

4.  Percutaneous transluminal angioplasty for total occlusion of middle cerebral arteries.

Authors:  T Mori; K Mori; M Fukuoka; S Honda
Journal:  Neuroradiology       Date:  1997-01       Impact factor: 2.804

5.  Cerebral revascularization for ischemic disease in the 21st century.

Authors:  Nicholas C Bambakidis; Shakeel A Chowdhry
Journal:  J Neurointerv Surg       Date:  2010-09       Impact factor: 5.836

6.  Failure of extracranial-intracranial arterial bypass to reduce the risk of ischemic stroke. Results of an international randomized trial.

Authors: 
Journal:  N Engl J Med       Date:  1985-11-07       Impact factor: 91.245

Review 7.  Cerebrovascular reserve and stroke risk in patients with carotid stenosis or occlusion: a systematic review and meta-analysis.

Authors:  Ajay Gupta; J Levi Chazen; Maya Hartman; Diana Delgado; Nikesh Anumula; Huibo Shao; Madhu Mazumdar; Alan Z Segal; Hooman Kamel; Dana Leifer; Pina C Sanelli
Journal:  Stroke       Date:  2012-11       Impact factor: 7.914

8.  Chronic middle cerebral artery occlusion: a hemodynamic and metabolic study with positron-emission tomography.

Authors:  M Tanaka; E Shimosegawa; K Kajimoto; Y Kimura; H Kato; N Oku; M Hori; K Kitagawa; J Hatazawa
Journal:  AJNR Am J Neuroradiol       Date:  2008-07-24       Impact factor: 3.825

9.  Endovascular recanalization for chronic symptomatic middle cerebral artery total occlusion.

Authors:  Ning Ma; Da-Peng Mo; Feng Gao; Zhong-Rong Miao
Journal:  J Neurointerv Surg       Date:  2012-04-11       Impact factor: 5.836

  9 in total
  1 in total

1.  Endovascular recanalisation with drug coated balloon for chronic symptomatic middle cerebral artery total occlusion.

Authors:  Jun Zhang; Xiao Zhang; Jin-Ping Zhang; Ju Han
Journal:  BMJ Case Rep       Date:  2018-03-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.